Skip to content

Aprea Therapeutics, Inc.

APRE· NasdaqCore metricsCIK 1781983

Pharmaceutical preparations552 peers

Last sale
Nov 11, 2026 · +0.45%
Market cap
$6.37M
14.19M shares
Filings
446
—
—
—
-$4.81M
Q3 2026N/M FY25 yoy
-$5.17M
Q3 2026N/M FY25 yoy
-$9.78M
Q3 2026derivedN/M FY24 yoy
-$0.09
Q3 2026N/M FY25 yoy
$37.85M
Q3 2026−36.1% FY25 yoy
$6.37M
—
—
0.2×
—
—

FY2025 figures · derived

Price

$0.448964.37%$0.8111past year
Nov 11, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$7.04MFY 2025
$37.88M0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$7,043,035reported
FY 20242024-12-31$9,363,537reported
FY 20232023-12-31$7,627,491reported
FY 20222022-12-31$16,402,273reported
FY 20212021-12-31$23,895,875reported
FY 20202020-12-31$37,879,325reported
FY 20192019-12-31$20,950,672reported
FY 20182018-12-31$14,194,732reported
FY 20172017-12-31$13,392,631reported

Pharmaceutical preparations

Aprea Therapeutics, Inc. is the 445th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Aprea Therapeutics, Inc. · CIK 1781983 · Engraved from SEC EDGAR